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Introduction
Burn injury is traditionally referred to as a common trig-
gering cause for acute coagulopathy. Even though there
is extensive literature exploring coagulopathy in trauma
patients, few studies have focused on management of
coagulopathy in specialized burn units.
Objectives
The aim of this study was to evaluate physician views,
considerations and practices regarding the perioperative
use of specific coagulation factors in burn patients.
Methods
Three hundred and fifty questionnaires were distributed
via electronic mail to burn specialists. Participation in the
survey was voluntary and anonymous. The questionnaire
consisted of two parts: the first collected physician and
institutional demographics, and the second explored the
opinions and attitudes of the specialists regarding perio-
perative coagulopathy diagnosis and treatment.
Results
There was a 16 % response rate. The majority of the
responders (74.5%) stated that no specific scoring sys-
tem is used in their department to detect coagulopathy.
More than half (56%) of specialists from Europe and
82% of specialists from North America recommend
treatment with fibrinogen concentrate or cryoprecipitate
if significant bleeding is accompanied by thromboelasto-
metric signs of a functional fibrinogen deficit or a
plasma fibrinogen level of less than 1.5 to 2.0 g/L, while
64% of doctors from other regions do not use fibrinogen
concentrate or cryoprecipitate. Prothrombin complex
concentrate is the most commonly used specific coagu-
lation factor in Europe (40%), but it is not commonly
used in N. America (9%) and in other regions (7.1%).
Thrombin and fibrin sealant are the most common topi-
cal factors applied intraoperatively in burn patients to
stop bleeding in N. America (72.7% and 82%, respec-
tively). The most common topical factor used intraopera-
tively in Europe is fibrin sealant (40%), while in other
regions topical factors are rarely used (14.3 %).
Conclusions
Burn ICU physicians do not use specific scoring system to
detect coagulopathy in burn patients. Fibrinogen concen-
trate, prothrombin complex and cryoprecipitate are the
most commonly used coagulation factors in bleeding burn
patients in Europe and North America. Thrombin and
fibrin sealant are the most common topical factors applied
intraoperatively in burn patients to stop bleeding. Extre-
mely low rate of specialists from other regions implements
specific treatment options in burn patients with periopera-
tive coagulopathy and bleeding.
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